Nov 20 (Reuters) - Health Canada
* INFORMATION UPDATE - HEALTH CANADA UPDATE ON TAMOXIFEN SHORTAGE
* HEALTH CANADA - FOR PAST SEVERAL WEEKS, APOTEX, ASTRAZENECA CANADA, TEVA CANADA HAVE REPORTED TAMOXIFEN SHORTAGES ON DRUG SHORTAGES CANADA WEBSITE
* HEALTH CANADA - REASONS FOR TAMOXIFEN SHORTAGE REPORTED BY COS INCLUDED UNEXPECTED MANUFACTURING DISRUPTIONS & INCREASED DEMAND
* HEALTH CANADA - WHILE TAMOXIFEN REMAINS AVAILABLE WITHIN HEALTHCARE SYSTEM, SUPPLY LEVELS HAVE BEEN LOWER THAN NORMAL
* HEALTH CANADA - MITIGATION MEASURES FOR TAMOXIFEN SHORTAGE INCLUDED EXPLORING ACCESS TO INTERNATIONAL SUPPLY
* HEALTH CANADA - ASTRAZENECA CANADA AND APOTEX HAVE BEEN ABLE TO EXPEDITE TAMOXIFEN SUPPLY
* HEALTH CANADA - ASTRAZENECA CANADA, APOTEX NOW REPORTING EARLIER ANTICIPATED SHORTAGE END DATES OF DEC 6, 2019, AND DEC 31, 2019, RESPECTIVELY
* HEALTH CANADA - TEVA CANADA CONTINUES TO REPORT AN ANTICIPATED TAMOXIFEN SHORTAGE END DATE OF JAN 31, 2020